Who is sponsoring NCT07472881?

NCT07472881 is sponsored by Chang Gung Memorial Hospital.

What drugs are being tested in NCT07472881?

Interventions in NCT07472881: Multi-acupoint low-level laser therapy, Sham Laser irradiation, Diet and exercise guidance.

What condition does NCT07472881 study?

NCT07472881 studies Menopause, Perimenopause, Obesity, Overweight.

Is NCT07472881 still recruiting?

NCT07472881 is currently recruiting now. Last updated 20 March 2026.

Last reviewed 2026-03-20 · How we verify

NCT07472881

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Multi-Acupoint Laser Therapy for Body Shape and Composition in Obese Menopausal Women

Recruiting now NA Last updated 20 March 2026

What this trial tests

NA trial testing Multi-acupoint low-level laser therapy in Menopause in 40 participants. Currently enrolling.

Timeline

16 March 2026

Primary endpoint
24 January 2029

24 January 2029

Quick facts

Lead sponsor	Chang Gung Memorial Hospital
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	40
Start date	16 March 2026
Primary completion	24 January 2029
Estimated completion	24 January 2029
Sites	1 location across Taiwan

Drugs / interventions tested

Multi-acupoint low-level laser therapy
Sham Laser irradiation — full drug profile →
Diet and exercise guidance

Conditions studied

Menopause — all drugs for Menopause →
Perimenopause — all drugs for Perimenopause →
Obesity — all drugs for Obesity →
Overweight — all drugs for Overweight →

Sponsor

Chang Gung Memorial Hospital

Who can join

Adults 45 to 55, female only, with Menopause or Perimenopause. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to integrate Traditional Chinese Medicine (TCM) theory and therapeutic methods with modern low-level laser stimulation on corresponding acupoints, applying this combined approach to the field of weight management in menopausal women. The trial aims to investigate whether lifestyle modifications in accordance with WHO guidelines (dietary control and exercise), combined with adjunctive low-level laser acupuncture, can enhance weight reduction and improve body composition more effectively than standard lifestyle interventions alone.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Menopause

Currently open trials in the same condition.

NCT06975111 — Focusing on the Menopausal Transition to Improve Mid-Life Women's Health · Phase 2, PHASE3 · recruiting
NCT07135232 — The Effects of Resistance Training and a Plant-Based Supplement on Perimenopausal Symptoms and Muscle Health. · NA · recruiting
NCT07393672 — Effects of Hemp-Derived Cannabinoids on Menopause Symptoms · Phase 2 · recruiting
NCT07412093 — The Effect of Progressive Relaxation Exercises and Planned Education on Menopausal Symptoms, Perceived Stress, and Anxie · NA · active not recruiting
NCT07378787 — Time-Restricted Eating in Combination With a Low Glycaemic Index Diet on Cognitive Function, Biological Ageing and Metab · NA · recruiting

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

NCT07419789 — Precision Care for Older Persons · NA · not yet recruiting
NCT07248345 — Virtual Reality Intervention for Family Caregivers of Persons Living With Dementia · NA · not yet recruiting
NCT07036978 — Metabolomic and Immune-Microbiome Profiling for Unresectable Pancreatic Cancer · not yet recruiting
NCT07489833 — Metabolomic Pathways and Traditional Chinese Medicine Body Constitution in Cancer-related Fatigue · not yet recruiting
NCT07496528 — The ACURE Trial: Acupuncture for Colorectal Recovery · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07472881 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chang Gung Memorial Hospital
Last refreshed: 20 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07472881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing